Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Giovanni Baraldi

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Current Topics in Medicinal Chemistry|December 8, 2004
Agonists and antagonists acting at P2X7 receptorPier Giovanni Baraldi, Francesco Di Virgilio, Romeo Romagnoli
Drug Discovery Today. Technologies|September 21, 2013
Allosteric modulation of A1-adenosine receptor: a reviewMaría Kimatrai-Salvador, Pier Giovanni Baraldi, Romeo Romagnoli
Journal of Medicinal Chemistry|April 2, 2010
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agentsPier Giovanni Baraldi, Delia Preti, Serena Materazzi, et al.
Bioorganic & Medicinal Chemistry|May 9, 2003
Benzoyl nitrogen mustard derivatives of benzoheterocyclic analogues of netropsin: synthesis and biological activityPier Giovanni Baraldi, Romeo Romagnoli, Nicoletta Bianchi, et al.
Journal of Medicinal Chemistry|April 4, 2012
Medicinal chemistry of A₃ adenosine receptor modulators: pharmacological activities and therapeutic implicationsPier Giovanni Baraldi, Delia Preti, Pier Andrea Borea, et al.
Current Drug Targets. Cardiovascular & Haematological Disorders|February 22, 2005
Leukocyte P2 receptors: a novel target for anti-inflammatory and anti-tumor therapyFrancesco Di Virgilio, O Roberto Baricordi, Romeo Romagnoli, et al.
Chemical Reviews|January 8, 2016
Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor AgonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Pier Andrea Borea, et al.
Chemical Reviews|January 10, 2008
Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utilityPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Stefania Gessi, et al.
Handbook of Experimental Pharmacology|July 30, 2009
Recent developments in A2B adenosine receptor ligandsRao V Kalla, Jeff Zablocki, Mojgan Aghazadeh Tabrizi, et al.
Current Topics in Medicinal Chemistry|February 3, 2004
Distamycin A as stem of DNA minor groove alkylating agentsPier Giovanni Baraldi, Maria del Carmen Nûnez, Antonio Espinosa, et al.
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Current Topics in Medicinal Chemistry|December 8, 2004
Agonists and antagonists acting at P2X7 receptorPier Giovanni Baraldi, Francesco Di Virgilio, Romeo Romagnoli
Drug Discovery Today. Technologies|September 21, 2013
Allosteric modulation of A1-adenosine receptor: a reviewMaría Kimatrai-Salvador, Pier Giovanni Baraldi, Romeo Romagnoli
Journal of Medicinal Chemistry|April 2, 2010
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agentsPier Giovanni Baraldi, Delia Preti, Serena Materazzi, et al.
Bioorganic & Medicinal Chemistry|May 9, 2003
Benzoyl nitrogen mustard derivatives of benzoheterocyclic analogues of netropsin: synthesis and biological activityPier Giovanni Baraldi, Romeo Romagnoli, Nicoletta Bianchi, et al.
Journal of Medicinal Chemistry|April 4, 2012
Medicinal chemistry of A₃ adenosine receptor modulators: pharmacological activities and therapeutic implicationsPier Giovanni Baraldi, Delia Preti, Pier Andrea Borea, et al.
Current Drug Targets. Cardiovascular & Haematological Disorders|February 22, 2005
Leukocyte P2 receptors: a novel target for anti-inflammatory and anti-tumor therapyFrancesco Di Virgilio, O Roberto Baricordi, Romeo Romagnoli, et al.
Chemical Reviews|January 8, 2016
Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor AgonistsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Pier Andrea Borea, et al.
Chemical Reviews|January 10, 2008
Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utilityPier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Stefania Gessi, et al.
Handbook of Experimental Pharmacology|July 30, 2009
Recent developments in A2B adenosine receptor ligandsRao V Kalla, Jeff Zablocki, Mojgan Aghazadeh Tabrizi, et al.
Current Topics in Medicinal Chemistry|February 3, 2004
Distamycin A as stem of DNA minor groove alkylating agentsPier Giovanni Baraldi, Maria del Carmen Nûnez, Antonio Espinosa, et al.
Pageof 16